| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer
1 company
Kaiser Peter is a Chief Development Officer at Ocular Therapeutix, Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $2.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | OCUL Ocular Therapeutix, Inc. | Chief Development Officer | Sell | 2,810 | $8.28 | $23,266.80 | -1.0% | - | - | |
| Nov 24, 2025 | OCUL Ocular Therapeutix, Inc | Chief Development Officer | Sell | 3,007 | $12.02 | $36,144.14 | -1.5% | -30.4% | - | |
| Oct 2, 2025 | OCUL Ocular Therapeutix, Inc | Chief Development Officer | Sell | 9,653 | $11.03 | $106,472.59 | -4.7% | +9.8% | - | |
| Aug 25, 2025 | OCUL Ocular Therapeutix, Inc | Chief Development Officer | Sell | 3,011 | $12.04 | $36,252.44 | -1.5% | +1.9% | - | |
| May 23, 2025 | OCUL Ocular Therapeutix, Inc | Chief Development Officer | Sell | 2,974 | $7.17 | $21,323.58 | -1.4% | +66.2% | - | |
| Feb 24, 2025 | OCUL Ocular Therapeutix, Inc | Chief Development Officer | Sell | 3,009 | $6.87 | $20,671.83 | -1.4% | +3.3% | +33.3% | |
| Nov 25, 2024 | OCUL Ocular Therapeutix, Inc | Chief Development Officer | Sell | 2,897 | $9.01 | $26,101.97 | -1.3% | -26.1% | +33.4% |